A systematic guide for medical device manufacturers on preparing technical documentation for overseas registration of point-of-care testing (POCT) products, covering regulatory classification, evidence reuse, common pitfalls, and cross-border registration strategy.
Key Takeaways
Preparing technical dossiers for overseas registration of POCT products requires systematic planning based on the target country's medical device regulatory framework and product risk classification. Manufacturers should first determine whether the product falls within the target country's medical device regulatory scope, then identify the registration pathway and applicant entity based on product classification. Core technical documents (e.g., risk management reports, performance validation, clinical evidence) can be reused from NMPA, CE, FDA, or ISO 13485/MDSAP systems, but local adaptation is required, including language translation, standards gap analysis, and supplementation of local regulatory requirements.
Common risks include failing to identify local special requirements (e.g., U.S. CLIA waiver, EU IVDR transitional provisions, local clinical requirements in Southeast Asia), neglecting the responsibilities of the local authorized representative, failing to adjust labels and instructions for target country formats, and lacking post-market surveillance plans. Manufacturers should form cross-functional teams, engage local agents or consultants early, prepare technical files in a modular format, and then customize supplements for each country to reduce duplication costs and deficiency risks in multi-country registrations.
For Chinese medical device manufacturers, a prudent approach is to first conduct product classification and documentation gap assessment, then determine whether NMPA, CE, FDA, ISO 13485, or other market documentation can be reused. Target market registration typically impacts technical files, authorized representatives, importer coordination, label language, quality system certificates, and subsequent change control. If the project is driven solely by 'which documents to submit,' deficiencies or rework may occur in model coverage, evidence chain consistency, labeling claims, and certificate control. AIMEILI recommends that manufacturers integrate this issue into a unified GHWP member country and multi-country market access strategy, using one set of reusable core technical files to support local adaptation across markets, rather than rebuilding files from scratch for each country.
Need a registration pathway assessment?
Send product type, intended use, target countries and existing certificates. AIMEILI can help evaluate registration pathway, documentation gaps and compliance risks.
Contact AIMEILI